1. Home
  2. MREO vs ILPT Comparison

MREO vs ILPT Comparison

Compare MREO & ILPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • ILPT
  • Stock Information
  • Founded
  • MREO 2015
  • ILPT 2017
  • Country
  • MREO United Kingdom
  • ILPT United States
  • Employees
  • MREO N/A
  • ILPT N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • ILPT Real Estate Investment Trusts
  • Sector
  • MREO Health Care
  • ILPT Real Estate
  • Exchange
  • MREO Nasdaq
  • ILPT Nasdaq
  • Market Cap
  • MREO 311.8M
  • ILPT 366.2M
  • IPO Year
  • MREO N/A
  • ILPT 2018
  • Fundamental
  • Price
  • MREO $1.84
  • ILPT $5.61
  • Analyst Decision
  • MREO Strong Buy
  • ILPT
  • Analyst Count
  • MREO 5
  • ILPT 0
  • Target Price
  • MREO $7.40
  • ILPT N/A
  • AVG Volume (30 Days)
  • MREO 1.6M
  • ILPT 244.9K
  • Earning Date
  • MREO 11-10-2025
  • ILPT 10-28-2025
  • Dividend Yield
  • MREO N/A
  • ILPT 3.55%
  • EPS Growth
  • MREO N/A
  • ILPT N/A
  • EPS
  • MREO N/A
  • ILPT N/A
  • Revenue
  • MREO $500,000.00
  • ILPT $445,459,000.00
  • Revenue This Year
  • MREO N/A
  • ILPT $3.26
  • Revenue Next Year
  • MREO $72.16
  • ILPT $1.33
  • P/E Ratio
  • MREO N/A
  • ILPT N/A
  • Revenue Growth
  • MREO N/A
  • ILPT 1.08
  • 52 Week Low
  • MREO $1.47
  • ILPT $2.45
  • 52 Week High
  • MREO $4.29
  • ILPT $6.57
  • Technical
  • Relative Strength Index (RSI)
  • MREO 45.03
  • ILPT 51.44
  • Support Level
  • MREO $1.65
  • ILPT $5.31
  • Resistance Level
  • MREO $1.93
  • ILPT $5.63
  • Average True Range (ATR)
  • MREO 0.12
  • ILPT 0.19
  • MACD
  • MREO -0.02
  • ILPT 0.02
  • Stochastic Oscillator
  • MREO 36.00
  • ILPT 59.05

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About ILPT Industrial Logistics Properties Trust of Beneficial Interest

Industrial Logistics Properties Trust is a real estate investment trust. It owns and leases industrial and logistics properties throughout the United States. The company's investment portfolio includes industrial lands in Hawaii and industrial and logistics properties in other states. Rental revenue is earned from Hawaii Properties and Mainland Properties.

Share on Social Networks: